journal cover

Evaluation and Management of Hematopoietic Failure in Dyskeratosis Congenita

Hematology/oncology Clinics of North America

Jul 27, 2018

Suneet Agarwal

Abstract

Dyskeratosis congenita (DC) is a rare, inherited bone marrow failure (BMF) syndrome characterized by variable manifestations and ages of onset, and predisposition to cancer. DC is one of a spectrum of diseases caused by mutations in genes regulating telomere maintenance, collectively re...read more

Mentioned in this Paper

Telomere Recombination
Evaluation
Paroxysmal Nocturnal Hemoglobinuria
Subcortical Band Heterotopia
Dyskeratosis Congenita
Pancytopenia
Physiopathological
Genetic Predisposition to Disease
Dyskeratosis
Awareness
2
1
11

Similar Papers Found In These Feeds

Dana-Farber Cancer Institute

Dana-Farber Cancer Institute focuses on advancing cancer tratment through supporting clinical trials and translational research. Follow this feed to stay up to date on research from this institute.

Telomeres in Cancer (Keystone)

Telomeres protect our genetic data and are found at the end of chromosomes. When a cell divides, telomeres become shorter. This process has been associated with the development of cancer. Here is the latest research on telomeres in cancer.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Telomeres in Cancer

Telomeres protect our genetic data and are found at the end of chromosomes. When a cell divides, telomeres become shorter. This process has been associated with the development of cancer. Here is the latest research on telomeres in cancer.

Telomere Dysfunction

Telomere dysfunction in response to critical telomere shortening induces dna damage checkpoints that lead to cell cycle arrest and/or cell death.

Hereditary Cancer Syndromes

Hereditary cancer syndromes comprise 5% of all cancers and have an increased risk of early onset and of multiple or bilateral malignancies. Here is the latest research on hereditary cancer syndromes.

© 2020 Meta ULC. All rights reserved

Evaluation and Management of Hematopoietic Failure in Dyskeratosis Congenita

Hematology/oncology Clinics of North America

Jul 27, 2018

Suneet Agarwal

PMID: 30047419

DOI: 10.1016/j.hoc.2018.04.003

Abstract

Dyskeratosis congenita (DC) is a rare, inherited bone marrow failure (BMF) syndrome characterized by variable manifestations and ages of onset, and predisposition to cancer. DC is one of a spectrum of diseases caused by mutations in genes regulating telomere maintenance, collectively re...read more

Mentioned in this Paper

Telomere Recombination
Evaluation
Paroxysmal Nocturnal Hemoglobinuria
Subcortical Band Heterotopia
Dyskeratosis Congenita
Pancytopenia
Physiopathological
Genetic Predisposition to Disease
Dyskeratosis
Awareness
2
1
11
/papers/evaluation-and-management-of-hematopoietic/30047419